Healthcare & Life Sciences
NxThera, Inc.
United States
acquired
acquired
Stage
1
Investors
About
NxThera, Inc. developed and marketed a minimally invasive medical treatment for enlarged prostate (BPH) and prostate cancer. The company was acquired by Boston Scientific in April 2018.
Explore NxThera, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.